These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20799266)

  • 1. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs.
    Silva CA; Bonfa E; Østensen M
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1682-90. PubMed ID: 20799266
    [No Abstract]   [Full Text] [Related]  

  • 2. Slow-acting antirheumatic drugs and immunosuppressives.
    Baillieres Clin Rheumatol; 1990 Dec; 4(3):405-704. PubMed ID: 2093436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
    Mariani L; Baratelli M
    Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inflammatory rheumatism and fundamentals of its drug therapy].
    Borkenstein E
    Wien Med Wochenschr; 1971 May; 121(22):449-52. PubMed ID: 5314609
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antirheumatics. 40].
    Mayr E
    Pharm Prax; 1969 Dec; 12():265-7 concl. PubMed ID: 4909744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current principles of anti-inflammatory therapy in rheumatology].
    Sigidin IaA
    Ter Arkh; 1978; 50(2):138-46. PubMed ID: 306139
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical pharmacology of antirheumatic preparations].
    Iasinovskii MA; Leshchinskii AF; Zuza ZI
    Klin Med (Mosk); 1973 Feb; 51(2):12-7. PubMed ID: 4540727
    [No Abstract]   [Full Text] [Related]  

  • 8. Disease-modifying agents and immunosuppressive drugs in the elderly.
    O'Callaghan JW; Brooks PM
    Clin Rheum Dis; 1986 Apr; 12(1):275-89. PubMed ID: 2872995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of chronic inflammatory rheumatic diseases.
    Kahn MF
    Scand J Rheumatol Suppl; 1975; 12():97-104. PubMed ID: 1084573
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-inflammatory drugs in rheumatic diseases.
    Cosh JA
    Practitioner; 1974 Oct; 213(1276 SPEC NO):519-26. PubMed ID: 4376236
    [No Abstract]   [Full Text] [Related]  

  • 11. Choice of anti-inflammatory drugs in the rheumatic diseases.
    Downie WW; Wright V
    Practitioner; 1977 Oct; 219(1312):463-8. PubMed ID: 74069
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of nonsteroidal antiinflammatory drugs in rheumatic diseases.
    Spector R
    J Iowa Med Soc; 1981 Dec; 71(12):538-9, 542. PubMed ID: 6977004
    [No Abstract]   [Full Text] [Related]  

  • 13. Geriatric rheumatology: safe use of potentially toxic antirheumatics.
    Melnyk V
    Geriatrics; 1988 Jul; 43(7):83-7, 90. PubMed ID: 3290060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases.
    Asten P; Barrett J; Symmons D
    J Rheumatol; 1999 Aug; 26(8):1705-14. PubMed ID: 10451066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma in rheumatic diseases.
    Louthrenoo W; Kasitanon N; Mahanuphab P; Bhoopat L; Thongprasert S
    Semin Arthritis Rheum; 2003 Apr; 32(5):326-33. PubMed ID: 12701043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the field of rheumatic and collagen diseases].
    Dimitriu CG; Nestor R
    Med Interna (Bucur); 1972 Jul; 24(7):785-92. PubMed ID: 4263092
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antirheumatic drugs. 40].
    Mayr E
    Pharm Prax; 1969; 10():234-40 contd. PubMed ID: 4908587
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer anti-rheumatic drugs.
    Abruzzo JL
    Ann Intern Med; 1978 Jul; 89(1):131-3. PubMed ID: 307359
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
    Molloy ES; Calabrese LH
    Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comprehensive review of the possibilities and limits of drug therapy of rheumatic diseases].
    Mirtl B
    Wien Med Wochenschr; 1982 Dec; 132(23-24):603-6. PubMed ID: 6984570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.